Literature DB >> 14971977

Prediction of maximal VO2 from a submaximal StairMaster test in young women.

Jane L P Roy1, Joe F Smith, Phillip A Bishop, Christopher Hallinan, Minqi Wang, Gary R Hunter.   

Abstract

The StairMaster 4000 PT is a popular step ergometer which provides a submaximal test protocol (SM Predicted VO(2)max) for the prediction of VO(2)max (ml.kg(-1).min(-1)). The purpose of this study was to evaluate the SM Predicted VO(2)max protocol by comparing it to results from a VO(2)max treadmill test in 20 young healthy women aged 20-25 years. Subjects were 10 step-trained (ST) women who had performed aerobic activities and exercised on a step ergometer for 20-30 minutes at least 3 times per week for the past 3 months, and 10 non-step-trained (NST) women who had performed aerobic activities no more than twice a week during the past 3 months and had no previous experience on a step ergometer. The SM Predicted VO(2)max protocol used 2 steady state heart rates between approximately 115-150 b.min(-1) to estimate VO(2)max. The Bruce maximal treadmill protocol (Actual VO(2)max) was used to measure VO(2)max by open circuit spirometry. Each subject performed both tests within a 7-day period. The means and standard deviations for the Actual VO(2)max tests were 39.8 +/- 6.1 ml.kg(-1).min(-1) for the ST group, 37.6 +/- 6.3 ml.kg(-1).min(-1) for the NST group, and 38.7 +/- 6.2 ml.kg(-1).min(-1) for the Total group (N = 20); and for the SM Predicted VO(2)max tests, means and standard deviations were 40.78 +/- 14.0 ml.kg(-1).min(-1), 30.9 +/- 4.8 ml.kg(-1).min(-1) and 35.9 +/- 11.4 ml.kg(-1).min(-1). There was no significant difference (p > 0.05) between the means of the Actual VO(2)max and SM Predicted VO(2)max test for the Total group (N = 20) or the ST group (n = 10), but a significant difference (p < 0.05) was shown for the NST group. The coefficient of determination (R(2)) and standard error of estimate (SEE) for the SM Predicted VO(2)max and Actual VO(2)max tests were R(2) = 0.18, SEE = 5.72 ml.kg(-1).min(-1) for the Total group; R(2) = 0.00, SEE = 6.68 ml.kg(-1).min(-1) for the NST group; and R(2) = 0.33, SEE = 5.32 ml.kg(-1).min(-1) for ST group. In conclusion, the SM Predicted VO(2)max test has acceptable accuracy for the ST group, but significantly underpredicted the NST group by almost 7 ml; and, as demonstrated by the high SEEs, it has a low level of precision for both ST and NST subjects.

Entities:  

Mesh:

Year:  2004        PMID: 14971977

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  5 in total

Review 1.  Estimation of maximal oxygen uptake via submaximal exercise testing in sports, clinical, and home settings.

Authors:  Francesco Sartor; Gianluca Vernillo; Helma M de Morree; Alberto G Bonomi; Antonio La Torre; Hans-Peter Kubis; Arsenio Veicsteinas
Journal:  Sports Med       Date:  2013-09       Impact factor: 11.136

2.  Validity of a Newly-Designed Rectilinear Stepping Ergometer Submaximal Exercise Test to Assess Cardiorespiratory Fitness.

Authors:  Rubin Zhang; Likui Zhan; Shaoming Sun; Wei Peng; Yining Sun
Journal:  J Sports Sci Med       Date:  2017-08-08       Impact factor: 2.988

3.  Stair descending exercise using a novel automatic escalator: effects on muscle performance and health-related parameters.

Authors:  Vassilis Paschalis; Anastasios A Theodorou; George Panayiotou; Antonios Kyparos; Dimitrios Patikas; Gerasimos V Grivas; Michalis G Nikolaidis; Ioannis S Vrabas
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

4.  Submaximal Testing to Estimate Aerobic Capacity Using a Matrix C5x Stepmill.

Authors:  Lauren von Schaumburg; Kelly R Laurson; David Q Thomas; Kristen M Lagally
Journal:  J Hum Kinet       Date:  2022-09-08       Impact factor: 2.923

5.  Feasibility of exercising adults with asthma: a randomized pilot study.

Authors:  Amy Boyd; Celeste T Yang; Kim Estell; Craig Tuggle Ms; Lynn B Gerald; Mark Dransfield; Marcas Bamman; James Bonner; T Prescott Atkinson; Lisa M Schwiebert
Journal:  Allergy Asthma Clin Immunol       Date:  2012-08-03       Impact factor: 3.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.